172 results
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
) Kimberly J. Tzoumakas 2. To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered
8-K
2ps2yskd190hqff
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
q1tyys17fnz76
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
6mukxn uoj9hwa0
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am